Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1991 6
1992 5
1993 8
1994 2
1996 3
1997 11
1998 5
1999 7
2000 3
2001 4
2002 3
2003 5
2004 2
2005 3
2006 3
2007 5
2008 1
2009 1
2010 3
2011 2
2013 1
2017 1
2019 3
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Olanzapine. Pharmacokinetic and pharmacodynamic profile.
Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Callaghan JT, et al. Among authors: beasley cm. Clin Pharmacokinet. 1999 Sep;37(3):177-93. doi: 10.2165/00003088-199937030-00001. Clin Pharmacokinet. 1999. PMID: 10511917 Review.
Fluoxetine: activating and sedating effects.
Beasley CM Jr, Potvin JH. Beasley CM Jr, et al. Int Clin Psychopharmacol. 1993 Winter;8(4):271-5. Int Clin Psychopharmacol. 1993. PMID: 8277147 Review.
Reference Limits for Outlier Analyses in Randomized Clinical Trials.
Beasley CM Jr, Crowe B, Nilsson M, Wu L, Tabbey R, Hietpas RT, Dean R, Horn PS. Beasley CM Jr, et al. Ther Innov Regul Sci. 2017 Nov;51(6):683-737. doi: 10.1177/2168479017700679. Epub 2017 May 19. Ther Innov Regul Sci. 2017. PMID: 30227105
Safety of olanzapine.
Beasley CM Jr, Tollefson GD, Tran PV. Beasley CM Jr, et al. J Clin Psychiatry. 1997;58 Suppl 10:13-7. J Clin Psychiatry. 1997. PMID: 9265911
Fluoxetine and suicide.
Beasley CM Jr. Beasley CM Jr. BMJ. 1991 Nov 9;303(6811):1200. doi: 10.1136/bmj.303.6811.1200. BMJ. 1991. PMID: 1747625 Free PMC article. No abstract available.
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page